Journal
CANCER LETTERS
Volume 525, Issue -, Pages 84-96Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2021.10.034
Keywords
Wnt signaling; Cancer; Immunotherapy; beta-catenin; Tumor microenvironment
Categories
Funding
- Science and Technology Commission of Shanghai [18ZR1403900]
- National Natural Science Foundation of China [81872895]
- Jinan Innovation Team Project [2020GXRC041]
- project on joint translational research in the School of Pharmacy and Minhang Hospital [RO-MY201712]
Ask authors/readers for more resources
Abnormal activation of the Wnt/beta-catenin signaling pathway is closely related to tumorigenesis and immune surveillance, leading to increased resistance to immunotherapy.
Wnt/beta-catenin signaling is a highly conserved pathway that regulates cell proliferation, differentiation, apoptosis, stem cell self-renewal, tissue homeostasis, and wound healing. Dysregulation of the Wnt pathway is intricately involved in almost all stages of tumorigenesis in various cancers. Through direct and/or indirect effects on effector T cells, T-regulatory cells, T-helper cells, dendritic cells, and other cytokine-expressing immune cells, abnormal activation of Wnt/beta-catenin signaling benefits immune exclusion and hinders T-cellmediated antitumor immune responses. Activation of Wnt signaling results in increased resistance to immunotherapies. In this review, we summarize the process by which Wnt signaling affects cancer and immune surveillance, and the potential for targeting the Wnt-signaling pathway via cancer immunotherapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available